Fstl1 promotes asthmatic airway remodeling by inducing

Journal of Immunology

Volumn 195, Issue 8, 2015, Pages 3546-3556

  Oncostatin, M ^a   Miller, Marina ^a   Beppu, Andrew ^a   Rosenthal, Peter ^a   Pham, Alexa ^a   Das, Sudipta ^a   Karta, Maya ^a   Song, Dae Jin ^b   Vuong, Christine ^a   Doherty, Taylor ^a   Croft, Michael ^c   Zuraw, Bruce ^a   Zhang, Xu ^d   Gao, Xiang ^e   Aceves, Seema ^a,f   Chouiali, Fazila ^g   Hamid, Qutayba ^g   Broide, David H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Korea University College of Medicine   (South Korea)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^e NANJING UNIVERSITY   (China)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLISTATIN LIKE 1 PROTEIN; FOLLISTATIN RELATED PROTEIN; ONCOSTATIN M; UNCLASSIFIED DRUG; ANTIBODY; FSTL1 PROTEIN, HUMAN; FSTL1 PROTEIN, MOUSE;

AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BONE MARROW CELL; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EOSINOPHILIC INFLAMMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RESPIRATORY TRACT INFLAMMATION; UPREGULATION; ANIMAL; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGY; MALE; PATHOLOGY; SIGNAL TRANSDUCTION;

AIRWAY REMODELING; ANIMALS; ANTIBODIES; ASTHMA; FEMALE; FOLLISTATIN-RELATED PROTEINS; HUMANS; MACROPHAGES; MALE; MICE; ONCOSTATIN M; SIGNAL TRANSDUCTION;

EID: 84943537300     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501105     Document Type: Article

References (41)

1. Broide, D. H. 2008. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J. Allergy Clin. Immunol. 121:560-570, quiz 571-572.
2. Cho, J. Y., M. Miller, K. J. Baek, J. W. Han, J. Nayar, S. Y. Lee, K. McElwain, S. McElwain, S. Friedman, and D. H. Broide. 2004. Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest. 113:551-560.
3. Shibanuma, M., J. Mashimo, A. Mita, T. Kuroki, and K. Nose. 1993. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur. J. Biochem. 217:13-19.
4. Tanaka, M., S. Ozaki, F. Osakada, K. Mori, M. Okubo, and K. Nakao. 1998. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. Int. Immunol. 10:1305-1314.
5. Chaly, Y., B. Hostager, S. Smith, and R. Hirsch. 2014. Follistatin-like protein 1 and its role in inflammation and inflammatory diseases. Immunol. Res. 59:266-272.
6. Ouchi, N., Y. Asaumi, K. Ohashi, A. Higuchi, S. Sono-Romanelli, Y. Oshima, and K. Walsh. 2010. Disco-interacting protein 2 homolog A functions as a follistatinlike 1 receptor. J. Biol. Chem. 285:7127-7134.
7. Geng, Y., Y. Dong, M. Yu, L. Zhang, X. Yan, J. Sun, L. Qiao, H. Geng, M. Nakajima, T. Furuichi, et al. 2011. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc. Natl. Acad. Sci. USA 108:7058-7063.
8. Sylva, M., A. F. Moorman, and M. J. van den Hoff. 2013. Follistatin-like 1 in vertebrate development. Birth Defects Res. C Embryo Today 99:61-69.
9. +-ATPase. Neuron 69:974-987.
10. Adams, D., B. Larman, and L. Oxburgh. 2007. Developmental expression of mouse Follistatin-like 1 (Fstl1): dynamic regulation during organogenesis of the kidney and lung. Gene Expr. Patterns 7:491-500.
11. Umezu, T., H. Yamanouchi, Y. Iida, M. Miura, and Y. Tomooka. 2010. Follistatin-like-1, a diffusible mesenchymal factor determines the fate of epithelium. Proc. Natl. Acad. Sci. USA 107:4601-4606.
12. Chan, Q. K., H. Y. Ngan, P. P. Ip, V. W. Liu, W. C. Xue, and A. N. Cheung. 2009. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis. Carcinogenesis 30:114-121.
13. Le Luduec, J. B., T. Condamine, C. Louvet, P. Thebault, J. M. Heslan, M. Heslan, E. Chiffoleau, and M. C. Cuturi. 2008. An immunomodulatory role for follistatin-like 1 in heart allograft transplantation. Am. J. Transplant. 8:2297-2306.
14. Oshima, Y., N. Ouchi, K. Sato, Y. Izumiya, D. R. Pimentel, and K. Walsh. 2008. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 117:3099-3108.
15. Miyamae, T., A. D. Marinov, D. Sowders, D. C. Wilson, J. Devlin, R. Boudreau, P. Robbins, and R. Hirsch. 2006. Follistatin-like protein-1 is a novel proinflammatory molecule. J. Immunol. 177:4758-4762.
16. Clutter, S. D., D. C. Wilson, A. D. Marinov, and R. Hirsch. 2009. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J. Immunol. 182:234-239.
17. Sundaram, G. M., J. E. Common, F. E. Gopal, S. Srikanta, K. Lakshman, D. P. Lunny, T. C. Lim, V. Tanavde, E. B. Lane, and P. Sampath. 2013. 'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature 495:103-106.
18. Chaly, Y., A. D. Marinov, L. Oxburgh, D. S. Bushnell, and R. Hirsch. 2012. FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expression. Arthritis Rheum. 64:1082-1088.
19. Kawabata, D., M. Tanaka, T. Fujii, H. Umehara, Y. Fujita, H. Yoshifuji, T. Mimori, and S. Ozaki. 2004. Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis Rheum. 50:660-668.
20. Ivanova, J. I., R. Bergman, H. G. Birnbaum, G. L. Colice, R. A. Silverman, and K. McLaurin. 2012. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J. Allergy Clin. Immunol. 129:1229-1235.
21. Le, A. V., J. Y. Cho, M. Miller, S. McElwain, K. Golgotiu, and D. H. Broide. 2007. Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J. Immunol. 178:7310-7316.
22. Pepe, C., S. Foley, J. Shannon, C. Lemiere, R. Olivenstein, P. Ernst, M. S. Ludwig, J. G. Martin, and Q. Hamid. 2005. Differences in airway remodeling between subjects with severe and moderate asthma. J. Allergy Clin. Immunol. 116:544-549.
23. Pae, S., J. Y. Cho, S. Dayan, M. Miller, A. D. Pemberton, and D. H. Broide. 2010. Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9. Immunogenetics 62:499-506.
24. Miller, M., P. Rosenthal, A. Beppu, J. L. Mueller, H. M. Hoffman, A. B. Tam, T. A. Doherty, M. D. McGeough, C. A. Pena, M. Suzukawa, et al. 2014. ORMDL3 transgenic mice have increased airway remodeling and airway responsiveness characteristic of asthma. J. Immunol. 192:3475-3487.
25. Miller, M., A. B. Tam, J. Y. Cho, T. A. Doherty, A. Pham, N. Khorram, P. Rosenthal, J. L. Mueller, H. M. Hoffman, M. Suzukawa, et al. 2012. ORMDL3 is an inducible lung epithelial gene regulating metalloproteases, chemokines, OAS, and ATF6. Proc. Natl. Acad. Sci. USA 109:16648-16653.
26. Dzik, J. M. 2014. Evolutionary roots of arginase expression and regulation. Front. Immunol. 5:544.
27. Suzukawa, M., M. Miller, P. Rosenthal, J. Y. Cho, T. A. Doherty, A. Varki, and D. Broide. 2013. Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice. J. Immunol. 190:5939-5948.
28. Woodman, L., S. Siddiqui, G. Cruse, A. Sutcliffe, R. Saunders, D. Kaur, P. Bradding, and C. Brightling. 2008. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-β 1. J. Immunol. 181:5001-5007.
29. Aceves, S. S., D. Chen, R. O. Newbury, R. Dohil, J. F. Bastian, and D. H. Broide. 2010. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J. Allergy Clin. Immunol. 126:1198-204.e4.
30. Broide, D. H., T. Lawrence, T. Doherty, J. Y. Cho, M. Miller, K. McElwain, S. McElwain, and M. Karin. 2005. Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase beta-dependent genes in airway epithelium. Proc. Natl. Acad. Sci. USA 102:17723-17728.
31. O'Hara, K. A., M. A. Kedda, P. J. Thompson, and D. A. Knight. 2003. Oncostatin M: an interleukin-6-like cytokine relevant to airway remodelling and the pathogenesis of asthma. Clin. Exp. Allergy 33:1026-1032.
32. Scaffidi, A. K., S. E. Mutsaers, Y. P. Moodley, R. J. McAnulty, G. J. Laurent, P. J. Thompson, and D. A. Knight. 2002. Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br. J. Pharmacol. 136:793-801.
33. Fritz, D. K., C. Kerr, R. Fattouh, A. Llop-Guevara, W. I. Khan, M. Jordana, and C. D. Richards. 2011. A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent. J. Immunol. 186:1107-1118.
34. Fritz, D. K., C. Kerr, L. Tong, D. Smyth, and C. D. Richards. 2006. Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6. J. Immunol. 176:4352-4360.
35. Simpson, J. L., K. J. Baines, M. J. Boyle, R. J. Scott, and P. G. Gibson. 2009. Oncostatin M (OSM) is increased in asthma with incompletely reversible airflow obstruction. Exp. Lung Res. 35:781-794.
36. Dong, Y., Y. Geng, L. Li, X. Li, X. Yan, Y. Fang, X. Li, S. Dong, X. Liu, X. Li, et al. 2015. Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice. J. Exp. Med. 212:235-252.
37. Doherty, T. A., P. Soroosh, N. Khorram, S. Fukuyama, P. Rosenthal, J. Y. Cho, P. S. Norris, H. Choi, S. Scheu, K. Pfeffer, et al. 2011. The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling. Nat. Med. 17:596-603.
38. Fahy, J. V. 2015. Type 2 inflammation in asthma-present in most, absent in many. Nat. Rev. Immunol. 15:57-65.
39. Wenzel, S. E. 2012. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 18:716-725.
40. Pothoven, K. L., J. E. Norton, K. E. Hulse, L. A. Suh, R. G. Carter, E. Rocci, K. E. Harris, S. Shintani-Smith, D. B. Conley, R. K. Chandra, et al. 2015. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. J. Allergy Clin. Immunol. In press.
41. Trejo Bittar, H. E., S. A. Yousem, and S. E. Wenzel. 2015. Pathobiology of severe asthma. Annu. Rev. Pathol. 10:511-545.